CLYM vs JCI · $85.8M cap vs P/E 44, rev $23.60B
Climb Bio Inc (CLYM) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Climb Bio Inc (CLYM) is a biotechnology company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
CLYM does not have a complete income-statement cache yet.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
CLYM currently screens at market cap $85.8M. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the CLYM and JCI stock pages for the full models.
Not investment advice.